Picard Medical (PMI) Liabilities and Shareholders Equity (2024 - 2026)

Picard Medical's Liabilities and Shareholders Equity history runs 3 years deep, the most recent figure standing at $11.2 million for Q1 2026.

• Quarterly Liabilities and Shareholders Equity changed N/A year-over-year to $11.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.0 million (up 387.3% YoY) and the FY2025 annual result came in at $22.5 million, up 86.25% from the prior year.
• Liabilities and Shareholders Equity was $11.2 million for Q1 2026 at Picard Medical, down from $22.5 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $22.5 million in Q4 2025 and bottomed at $11.2 million in Q1 2026.
• A 3-year average of $14.2 million and a median of $12.1 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Peak annual rise in Liabilities and Shareholders Equity reached 86.25% in 2025, while the deepest fall reached 86.25% in 2025.
• Picard Medical's Liabilities and Shareholders Equity stood at $12.1 million in 2024, then surged by 86.25% to $22.5 million in 2025, then plunged by 50.24% to $11.2 million in 2026.
• Business Quant data shows PMI's Liabilities and Shareholders Equity at $11.2 million in Q1 2026, $22.5 million in Q4 2025, and $13.5 million in Q3 2025.